New blood-thinning drugs hold promise, but pose risk

June 2010
Journal of Business (10756124);6/17/2010, Vol. 25 Issue 13, pB8
Trade Publication
The article reports that three new oral blood-thinning drugs that are nearing approval by the U.S. Food and Drug Administration are more convenient that the standard drug Coumadin but could cause dangerous interactions when taken alongside widely used prescription drugs and over-the-counter medicines.


Related Articles

  • Balancing your anticoagulant.  // Mayo Clinic Health Letter;Jun1998, Vol. 16 Issue 6, p2 

    Looks at concerns of drug interaction with anticoagulants, which include heparin and warfarin. Importance of consistency in medication and foods to maintain the proper levels of anticoagulant in the blood; Information on drugs which cause problems with anticoagulants.

  • Aspirin/clopidogrel/warfarin.  // Reactions Weekly;7/30/2011, Issue 1362, p9 

    The article describes the case of a 73-year-old woman who developed intramuscular haematomas resulting to femoral neuropathy while undergoing anticoagulant therapy with aspirin, clopidogrel and warfarin.

  • Apixaban.  // Reactions Weekly;Apr2015, Vol. 1546 Issue 1, p35 

    The article presents case report of a patient who experienced minor haemorrhage during treatment with apixaban.

  • Lack of pharmacokinetic interactions between argatroban and warfarin. Brown, Philip M.; Hursting, Marcie J. // American Journal of Health-System Pharmacy;11/1/2002, Vol. 59 Issue 21, p2078 

    The potential for pharmacokinetic interactions between argatroban and warfarin was studied. In a randomized, crossover study, healthy volunteers participated in three treatment periods, each separated by a nine-day washout interval. Drug regimens consisted of a single oral 7.5-mg dose of...

  • Quantity and quality of potential drug interactions with coumarin anticoagulants in the Netherlands. Fernie Penning-van Beest; Jeroen Koerselman // Pharmacy World & Science;Dec2007, Vol. 29 Issue 6, p671 

    Abstract Objective  Coumarin anticoagulants are prone to potentially life-threatening drug-drug interactions due to a combination of unfavorable properties. However, real life data on the actual occurrence are scarce. The aim of this study was to quantify and qualify potential...

  • Effect of Tolterodine on the Anticoagulant Actions and Pharmacokinetics of Single-dose Warfarin in Healthy Volunteers. Rahimy, Mohamad; Hallen, Bengt; Narang, Prem // Drug Research / Arzneimittel-Forschung (Editio Cantor Verlag fur;Dec2002, Vol. 52 Issue 12, p890 

    This randomized, double-blind, crossover study investigated the potential effects of tolterodine ((R)-N,N-diisopropyl-3-(2-hydroxy-5-methyl-phenyl)-3-phenylpropanamine, CAS 124937-51-5), an antimuscarinic agent for the treatment of the overactive bladder, on the anticoagulant actions and...

  • CME Questions.  // Alternative Medicine Alert;Jun2011, Vol. 14 Issue 6, p72 

    A quiz about herbal remedies' interaction with anticoagulant therapy is presented.

  • One Time to Skip Supplements. Kosecki, Danielle // Prevention;Sep2009, Vol. 61 Issue 9, p18 

    The article reveals that over 50 percent patients took natural remedies before surgery, but only 30 to 60 percent of such patients tell their doctors about such practice. It notes that natural remedies cause heart attack, stroke, allergic reactions and bleeding when combined with anesthetic and...

  • Author reply. Sangeeta Bhanwra; Kaza Ahluwalia // Journal of Pharmacology & Pharmacotherapeutics;Apr-Jun2014, Vol. 5 Issue 2, p169 

    A response from the author of the article "The new factor Xa inhibitor: Apixaban" in the 2014 issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics